Clinical Trial Results

Showing: All studies [change]
Condition: Breast Cancer Location: Washington 25 trials found
New Search
Filter
Trial Phase
Study Type
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Improving Genetic Counseling for BRCA+ Mothers
NAINTERVENTIONAL Washington D.C., District of Columbia
RECRUITING
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
PHASE1INTERVENTIONAL Beverly Hills, California +4 more
RECRUITING
X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
PHASE1INTERVENTIONAL Washington D.C., District of Columbia +3 more
RECRUITING
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
PHASE1INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
ETHAN - ET for Male BC
PHASE2INTERVENTIONAL Washington D.C., District of Columbia +4 more
RECRUITING
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
PHASE2INTERVENTIONAL Washington D.C., District of Columbia +4 more
RECRUITING
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Older Breast Cancer Patients: Risk for Cognitive Decline
N/AOBSERVATIONAL Washington D.C., District of Columbia
RECRUITING
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
NAINTERVENTIONAL Washington D.C., District of Columbia +3 more
RECRUITING
Childhood Cancer Survivor Study
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
PHASE3INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
PHASE1, PHASE2INTERVENTIONAL Washington D.C., District of Columbia +2 more
RECRUITING
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
PHASE1, PHASE2INTERVENTIONAL Santa Rosa, California +4 more
RECRUITING
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
N/AOBSERVATIONAL Washington D.C., District of Columbia
RECRUITING
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
N/AOBSERVATIONAL Anchorage, Alaska +4 more
RECRUITING
Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters)
NAINTERVENTIONAL Washington D.C., District of Columbia +2 more
RECRUITING
Abatacept in Immune Checkpoint Inhibitor Myocarditis
PHASE3INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
PHASE3INTERVENTIONAL Daphne, Alabama +4 more
RECRUITING
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Pan Tumor Rollover Study
PHASE2INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
PHASE2INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type